JP2020533415A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020533415A5 JP2020533415A5 JP2020536720A JP2020536720A JP2020533415A5 JP 2020533415 A5 JP2020533415 A5 JP 2020533415A5 JP 2020536720 A JP2020536720 A JP 2020536720A JP 2020536720 A JP2020536720 A JP 2020536720A JP 2020533415 A5 JP2020533415 A5 JP 2020533415A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- pharmaceutically acceptable
- acceptable salt
- antidepressants
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762557412P | 2017-09-12 | 2017-09-12 | |
| US62/557,412 | 2017-09-12 | ||
| PCT/US2018/050339 WO2019055369A1 (en) | 2017-09-12 | 2018-09-11 | USE OF GABOXADOL IN THE TREATMENT OF NARCOLEPSIA |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020533415A JP2020533415A (ja) | 2020-11-19 |
| JP2020533415A5 true JP2020533415A5 (https=) | 2021-10-21 |
Family
ID=65630168
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020536720A Pending JP2020533415A (ja) | 2017-09-12 | 2018-09-11 | ナルコレプシーの処置におけるガボキサドールの使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20190076409A1 (https=) |
| EP (1) | EP3661507A4 (https=) |
| JP (1) | JP2020533415A (https=) |
| KR (1) | KR20200053570A (https=) |
| CN (1) | CN111328282A (https=) |
| AU (1) | AU2018331326A1 (https=) |
| CA (1) | CA3075478A1 (https=) |
| IL (1) | IL272962A (https=) |
| MX (1) | MX2020002741A (https=) |
| WO (1) | WO2019055369A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2020533415A (ja) * | 2017-09-12 | 2020-11-19 | オービッド・セラピューティクス・インコーポレイテッドＯｖｉｄ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． | ナルコレプシーの処置におけるガボキサドールの使用 |
| JP2022514194A (ja) | 2018-11-21 | 2022-02-10 | セルテゴ セラピューティクス インコーポレイテッド | 自殺のリスクを低減し、うつ病を迅速に軽減するためのガボキサドール |
| MX2021016006A (es) | 2019-06-28 | 2022-04-07 | Univ Copenhagen | Tratamiento de trastornos del sistema nervioso central (snc) con perturbaciones del sueño. |
| MX2022014599A (es) | 2020-05-20 | 2022-12-16 | Certego Therapeutics Inc | Gaboxadol deuterado en anillo y su uso para el tratamiento de trastornos psiquiatricos. |
| US20250375429A1 (en) | 2024-05-29 | 2025-12-11 | Smarter Not Harder, Inc. | Obligate pairing of orthosteric and non-orthosteric gaba ligands in pharmaceutical formulations |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200528098A (en) * | 2003-12-18 | 2005-09-01 | Lundbeck & Co As H | Treatment of insomnia in human patients |
| US20050215521A1 (en) * | 2003-12-22 | 2005-09-29 | Karim Lalji | Modafinil combination therapy for improving sleep quality |
| US9480695B2 (en) * | 2011-09-29 | 2016-11-01 | The University Of Tokyo | Methods for inducing orexin neurons and agent for treating narcolepsy or eating disorder |
| US9050302B2 (en) * | 2013-03-01 | 2015-06-09 | Jazz Pharmaceuticals Ireland Limited | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
| US9359290B2 (en) * | 2013-03-13 | 2016-06-07 | Jazz Pharmaceuticals International Iii Limited | Treatment of cataplexy |
| US9682069B2 (en) * | 2015-07-17 | 2017-06-20 | Ovid Therapeutics Inc | Methods of treating Dravet syndrome |
| WO2017205606A1 (en) * | 2016-05-26 | 2017-11-30 | Ovid Therapeutics Inc. | Methods of treating behavioral syndromes using pipradrol |
| JP2020533415A (ja) * | 2017-09-12 | 2020-11-19 | オービッド・セラピューティクス・インコーポレイテッドＯｖｉｄ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． | ナルコレプシーの処置におけるガボキサドールの使用 |
-
2018
- 2018-09-11 JP JP2020536720A patent/JP2020533415A/ja active Pending
- 2018-09-11 KR KR1020207010674A patent/KR20200053570A/ko not_active Withdrawn
- 2018-09-11 MX MX2020002741A patent/MX2020002741A/es unknown
- 2018-09-11 US US16/127,375 patent/US20190076409A1/en not_active Abandoned
- 2018-09-11 WO PCT/US2018/050339 patent/WO2019055369A1/en not_active Ceased
- 2018-09-11 EP EP18856943.8A patent/EP3661507A4/en not_active Withdrawn
- 2018-09-11 CA CA3075478A patent/CA3075478A1/en active Pending
- 2018-09-11 CN CN201880072667.9A patent/CN111328282A/zh active Pending
- 2018-09-11 AU AU2018331326A patent/AU2018331326A1/en not_active Abandoned
-
2020
- 2020-02-27 IL IL272962A patent/IL272962A/en unknown
- 2020-03-25 US US16/829,423 patent/US20200222372A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020533415A5 (https=) | ||
| Stiskal et al. | Neonatal paroxetine withdrawal syndrome | |
| JP2004307506A5 (https=) | ||
| EP3970712A2 (en) | Solid oral dosage forms of 2r,6r-hydroxynorketamine or derivatives thereof | |
| RU2020125170A (ru) | Композиции и способы улучшения биодоступности 5-гидрокситриптофана | |
| AU2010211491B2 (en) | Medical use of 5-benzylaminosalicylic acid derivative or its salt | |
| JP2016506933A5 (https=) | ||
| JP2025508406A5 (https=) | ||
| JP4874397B2 (ja) | ムスカリン性受容体ｍ１拮抗剤を使用する精神状態の処置 | |
| CA2485736A1 (en) | Methods of treating gastrointestinal and genitourinary pain disorders using venlafaxine and derivatives | |
| JP2012036212A5 (https=) | ||
| TW200835477A (en) | Methods for treating depression | |
| JP2009542819A5 (https=) | ||
| JP2009542820A5 (https=) | ||
| CA2525524C (en) | Combination of the analeptic modafinil and an antidepressant for the treatment of depression | |
| JP2025504984A5 (https=) | ||
| JP2011516604A (ja) | 鬱病患者の自殺行動の予防治療のためのミルナシプラン塩酸塩の（１ｓ，２ｒ）鏡像異性体の使用 | |
| DK2533774T3 (en) | USE OF AGOMELATIN FOR THE PREPARATION OF MEDICINALS FOR THE TREATMENT OF OBSESSIVE-COMPULSIVE CONDITION (OCD) | |
| Gautam et al. | Levomilnacipran | |
| RU2009101146A (ru) | Лечение ожирения антагонистами мускаринового рецептора м1 | |
| RU2019123563A (ru) | Новые комбинации антагонистов н3-рецепторов и ингибиторов обратного захвата норадреналина и их терапевтическое применение | |
| JP2025500344A5 (https=) | ||
| MX2009001219A (es) | Composicion farmaceutica que contiene en combinacion saredutant y un inhibidor selectivo de recaptacion de serotonina o un inhibidor de recaptacion de serotonina/norepinefrina. | |
| RS51659B (sr) | Upotreba agomelatina za dobijanje lekova namenjenih tretmanu bipolarnih poremećaja | |
| RS50631B (sr) | Nova sprega agomelatina i inhibitora preuzimanja noradrenalina i farmaceutske smeše koje ih sadrže |